Please login to the form below

M3 (EU)

M3 is a global healthcare technology company and an effective digital communications platform, which is supported by strong communities and heritage. M3 delivers highly targeted impactful programs to over 3.8 million doctors across 248 markets; via its channels www.doctors.net.uk, www.m3medical.com,and www.networksinhealth.com.  

M3 drives innovation and creates connections with doctors globally via these communities in order to empower doctors in their day-to-day lives and drive positive outcomes for patients. As M3 has an intimate knowledge of what doctors want and need, we are able to offer clients deeper engagement models so they can cultivate their target audiences effectively. M3's combination of research capabilities, communications services (educational and promotional) and analytics enables us to deliver effective digital communications campaigns globally.

Press Releases

M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group
M3 is strengthening and growing its global operations with the acquisition of Vidal Group, a trusted provider of prescribing information and clinical decision support services to doctors and other HCPs in key markets including France, Germany, Spain and Latin America. This move complements M3’s existing business activities in Japan, the United States, United Kingdom, China, Korea and India.

White Papers and Resources

Healthcare in the Digital Age
Healthcare is changing. By understanding the needs of the physicians, and using innovative channels to make meaningful connections, pharma can ensure it continues to enjoy a mutually beneficial relationship.

Latest Tweets

Networks

Doctors.net.uk

Company Details

M3 (EU)

+44 (0)1235 828400

Contact Website

Address:
M3 (EU)
20 Western Avenue
Milton Park
Abingdon
Oxon
OX14 4SH
UK

Latest content on this profile

Healthcare in the Digital Age
Healthcare is changing. By understanding the needs of the physicians, and using innovative channels to make meaningful connections, pharma can ensure it continues to enjoy a mutually beneficial relationship.
M3 (EU)
M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group
M3 is strengthening and growing its global operations with the acquisition of Vidal Group, a trusted provider of prescribing information and clinical decision support services to doctors and other HCPs in key markets including France, Germany, Spain and Latin America. This move complements M3’s existing business activities in Japan, the United States, United Kingdom, China, Korea and India.
M3 (EU)